Results 291 to 300 of about 88,087 (318)
Some of the next articles are maybe not open access.

Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel

Current Opinion in Psychiatry, 2019
Purpose of review The implementation of pharmacogenetic testing in psychiatry is underway but is not yet standard protocol. Barriers to pharmacogenetics becoming standard practice are the lack of translation of evidence-based recommendations and ...
C. Bousman, A. Maruf, D. Müller
semanticscholar   +1 more source

Pharmacogenetics and Schizophrenia

Psychiatric Clinics of North America, 2007
The wide interindividual variability in clinical response and tolerability of antipsychotic medications has led investigators to postulate that these variabilities may be under genetic control. Although not always consistent, there are promising indications from emergent pharmacogenetic studies that efficacy of antipsychotic medications for the various
Adriana Foster   +2 more
openaire   +4 more sources

The Pharmacogenetics of Tramadol

Clinical Pharmacokinetics, 2015
Tramadol hydrochloride is used worldwide as an analgesic drug with a unique dual function. The metabolic enzymes cytochrome P450 (CYP) 3A4, CYP2B6, and CYP2D6 and the various transporters [adenosine triphosphate-binding cassette B1/multidrug resistance 1/P-glycoprotein, organic cation transporter 1, serotonin transporter (SERT), norepinephrine ...
Kim Brøsen   +4 more
openaire   +4 more sources

Pharmacogenetics in Psychiatry

2018
Mental illness represents a major health issue both at the individual and at the socioeconomical level. This is partly due to the current suboptimal treatment options: existing psychotropic medications, including antidepressants, antipsychotics, and mood stabilizers, are effective only in a subset of patients or produce partial response and they are ...
Corponi, Filippo   +2 more
openaire   +2 more sources

Pharmacogenetics and Psychiatry

Current Psychiatry Reports, 2004
Genetic factors play a significant role in predicting an individual's response to a drug. The response may be the desired therapeutic effect of the drug and also may be the undesirable development of adverse effects. This relationship between genes and drug response interests the pharmacogeneticist. This article aims to give an overview of the exciting
Basu, A, Tsapakis, E, Aitchison, K
openaire   +4 more sources

Pharmacogenetics

2018
Pharmacogenetics is the study of how genetics influences drug treatment outcomes. Much research has been conducted to identify and characterize gene variants that impact the pharmacokinetic and pharmacodynamic aspects of medications used to treat neurologic and psychiatric disorders.
openaire   +4 more sources

Pharmacogenetics of Psoriasis

Pharmacogenomics, 2010
Psoriasis is an inflammatory hyperproliferative skin disorder with a strong genetic predisposition. While many effective modalities are currently available for treating psoriasis, response to therapy is quite variable among patients. The genetic component underlying the response to pharmacotherapy in psoriasis is slowly beginning to emerge and ...
Proton Rahman, Darren D. O’Rielly
openaire   +3 more sources

Overview of Pharmacogenetics

Current Protocols in Pharmacology, 2003
AbstractPharmacogenetics is the study of relationships between genetic variation and inter‐individual differences of drug response. As the field has matured over the past 15 years, a remarkable diversity of pathways, variation types, and mechanisms have been found to be relevant pharmacogenetic factors.
openaire   +6 more sources

Sarcomas and Pharmacogenetics

Pharmacogenomics, 2005
Sarcomas are a heterogeneous group of tumors, requiring different chemotherapeutic approaches. Recently, several regimens for metastatic tumors were evaluated with respect to the different responses to conventional chemotherapy of the various histologic subtypes of sarcomas.
Paola Biason, Giuseppe Toffoli
openaire   +3 more sources

Home - About - Disclaimer - Privacy